GUANGJI PHARMA.(SZ:000952) Xin Lang Cai Jing·2025-10-31 02:11Core Viewpoint - Guangji Pharmaceutical's stock has shown fluctuations in recent trading, with a year-to-date increase of 10.19% but a recent decline over the past five days of 2.44% [1][2] Financial Performance - For the period from January to September 2025, Guangji Pharmaceutical reported revenue of 429 million yuan, a year-on-year decrease of 7.12%, while the net profit attributable to shareholders was -97.30 million yuan, an increase of 38.64% year-on-year [2][3] - The company has cumulatively distributed 132 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3] Stock Market Activity - As of October 31, Guangji Pharmaceutical's stock price was 6.81 yuan per share, with a market capitalization of 2.36 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on October 24, where it recorded a net buy of -2.12 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders was 24,200, a decrease of 5.13% from the previous period, with an average of 14,221 circulating shares per shareholder, an increase of 5.41% [2] - Notable institutional holdings include Huaxia CSI 500 Index Enhanced A and Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund, with the former being a new shareholder [3]